Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06463886

Striving Towards EmPowerment and Medication Adherence R01

A Randomized Control Trial of Striving Towards EmPowerment and Medication Adherence (STEP-AD)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
University of Miami · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a study for Black women living with HIV to test a counseling program for Black women living with HIV. This participant may be a good fit if the participant is a Black woman, living with HIV, has a history of trauma, and is currently taking Antiretroviral Therapy (ART) medicines

Conditions

Interventions

TypeNameDescription
BEHAVIORALSTEP-ADThis in-person STEP-AD intervention will consist of 10 sessions. Session 1: Life Steps Adherence Session 2: Psychoeducation on the treatment model Session 3: Substance Use and Enhancing Resilience Session 4: Trauma Impact Session 5: Cognitive Restructuring Session 6: Racial Discrimination Impact and Coping Session 7: HIV Stigma Impact and Coping Session 8: Gender-related Stressors and Coping Session 9: Body Image and Healthy Relationships Session 10: Practice, Review, and Relapse Prevention. Each session lasts for about 40 to 60 minutes.
BEHAVIORALEnhanced treatment as usual (E-TAU)Participants assigned to the E-TAU condition will receive 10 in person sessions to ensure comparable contact time with study staff and identical incentives. The first session will consist of a session on healthy living with HIV (CDC content on HIV 101 \[highlights importance of engaging in care, adhering to medication, finding support\], nutrition, and physical activity. The remaining 9 sessions will consist of neutral (daily events) writing. Women will be asked to write a description of their plans for the next 24 hours.

Timeline

Start date
2024-08-19
Primary completion
2029-06-01
Completion
2029-06-01
First posted
2024-06-18
Last updated
2025-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06463886. Inclusion in this directory is not an endorsement.